Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4.50 INR
Change Today -0.19 / -4.05%
Volume 152.0
PHAD On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

pharmaids pharmaceuticals lt (PHAD) Snapshot

Open
4.46
Previous Close
4.69
Day High
4.50
Day Low
4.46
52 Week High
07/29/15 - 4.69
52 Week Low
12/31/14 - 2.05
Market Cap
15.3M
Average Volume 10 Days
445.3
EPS TTM
-0.19
Shares Outstanding
3.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMAIDS PHARMACEUTICALS LT (PHAD)

Related News

No related news articles were found.

pharmaids pharmaceuticals lt (PHAD) Related Businessweek News

No Related Businessweek News Found

pharmaids pharmaceuticals lt (PHAD) Details

Pharmaids Pharmaceuticals Limited produces and markets pharmaceutical formulations in India. It offers allopathic, herbal ayurvedic, and natural drug formulations in various forms, such as tablets, capsules, liquids, powders, etc. The company was incorporated in 1989 and is based in Hyderabad, India.

Founded in 1989

pharmaids pharmaceuticals lt (PHAD) Top Compensated Officers

Chairman, Managing Director, Chairman of Remu...
Total Annual Compensation: 150.0K
Executive Director and Member of Stock Holder...
Total Annual Compensation: 72.0K
Compensation as of Fiscal Year 2014.

pharmaids pharmaceuticals lt (PHAD) Key Developments

Pharmaids Pharmaceuticals Ltd. Announces Unaudited Standalone Earnings Results for the Fourth Quarter and Audited Standalone Earnings Results for the Full Year Ended March 31, 2015

Pharmaids Pharmaceuticals Ltd. announced unaudited standalone earnings results for the fourth quarter and audited standalone earnings results for the full year ended March 31, 2015. For the quarter, the company reported total income from operations of INR 3.194 million against INR 4.044 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 1.624 million against INR 3.874 million a year ago. Loss from ordinary activities before tax was INR 1.639 million against INR 3.168 million a year ago. Loss for the period was INR 1.639 million against INR 3.168 million a year ago. Earnings per basic and diluted share were INR 0.48 against INR 0.93 a year ago. For the full year, the company reported total income from operations of INR 17.304 million against INR 14.052 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 2.287 million against INR 5.163 million a year ago. Loss from ordinary activities before tax was INR 1.060 million against INR 3.660 million a year ago. Loss for the period was INR 0.655 million against INR 3.543 million a year ago. Loss per basic and diluted share was INR 0.19 against earnings per basic and diluted share of INR 1.04 a year ago.

Pharmaids Pharmaceuticals Ltd., Board Meeting, May 29, 2015

Pharmaids Pharmaceuticals Ltd., Board Meeting, May 29, 2015. Agenda: To consider audited results.

Pharmaids Pharmaceuticals Ltd Appoints Seema Jain as an Additional Director

Pharmaids Pharmaceuticals Ltd. announced that Smt. Seema Jain has been appointed as an additional director of the company with effect from March 30, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHAD:IN 4.50 INR -0.19

PHAD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHAD.
View Industry Companies
 

Industry Analysis

PHAD

Industry Average

Valuation PHAD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.9x
Price/Book 0.9x
Price/Cash Flow 21.8x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMAIDS PHARMACEUTICALS LT, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.